Fumonisin B1 induces protein kinase C translocation via direct interaction with diacylglycerol binding site

J M Yeung1, H Y Wang, D B Prelusky

  • 1Food Research Division, Food Directorate, Health Protection Branch, Health Canada, Sir Frederick Banting Research Centre, Ottawa, Ontario, Canada.

Insights

Fumonisin B1 (FB1) activates protein kinase C (PKC) and causes its translocation, similar to tumor promoters. This provides a mechanism for FB1

Area of Science:

  • Toxicology
  • Molecular Biology
  • Biochemistry

Background:

  • Fumonisins, particularly fumonisin B1 (FB1), are known carcinogens in rats and suspected human carcinogens.
  • The precise mechanisms underlying fumonisin-induced carcinogenesis remain poorly understood.
  • Signal transduction pathways, including protein kinase C (PKC), are implicated in carcinogenesis.

Purpose of the Study:

  • To investigate whether fumonisin B1 (FB1) affects protein kinase C (PKC) activation and translocation.
  • To elucidate the cellular mechanisms by which FB1 may contribute to carcinogenesis.

Main Methods:

  • FB1's effect on PKC activity and subcellular distribution was assessed in rat cerebrocortical slices.
  • PKC activity was measured via histone phosphorylation.
  • PKC isozyme redistribution was evaluated using immunoblotting and [3H]PDBu binding assays.

Main Results:

  • FB1 induced a concentration-dependent translocation of PKC from the cytosol to the membrane, mirroring the effect of phorbol ester (PMA).
  • FB1's action on PKC translocation was inhibited by sphingosine and 4α-phorbol 12,13-didecanoate.
  • FB1 competed with phorbol ester binding, suggesting interaction with the diacylglycerol-binding site of PKC.

Conclusions:

  • FB1 directly activates and translocates PKC, acting on the same site as phorbol esters.
  • This FB1-induced PKC activation provides a plausible cellular mechanism for its carcinogenic activity.
  • The findings highlight a critical molecular pathway involved in fumonisin toxicity and carcinogenicity.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...